Alise Reicin's most recent trade in Tectonic Therapeutic Inc. was a trade of 859 Common Stock done at an average price of $19.8 . Disclosure was reported to the exchange on June 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tectonic Therapeutic Inc. | Alise S. Reicin | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.81 per share. | 20 Jun 2025 | 859 | 213,485 | - | 19.8 | 17,017 | Common Stock |
| Sana Biotechnology Inc | Alise S. Reicin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc. | Alise S. Reicin | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 101,953 | 101,953 | - | - | Employee Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc. | Alise S. Reicin | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 36,047 | 214,344 | - | 0 | Common Stock | |
| Tectonic Therapeutic Inc. | Alise S. Reicin | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2024 | 11,717 | 178,297 | - | 0 | Common Stock | |
| Tectonic Therapeutic Inc. | Alise S. Reicin | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2024 | 6,000 | 6,000 | - | - | Employee Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc. | Alise S. Reicin | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 289,600 | 289,600 | - | - | Employee Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc. | Alise S. Reicin | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 166,580 | 166,580 | - | - | Common Stock | |
| Tectonic Therapeutic Inc. | Alise S. Reicin | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 124,530 | 124,530 | - | - | Common Stock | |
| Tectonic Therapeutic Inc. | Alise S. Reicin | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 33,923 | 33,923 | - | - | Employee Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc. | Alise S. Reicin | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 23,380 | 23,380 | - | - | Employee Stock Option (Right to Buy) | |
| Sana Biotechnology Inc | Alise S. Reicin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Sana Biotechnology Inc | Alise S. Reicin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 54,278 | 54,278 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc. | Alise S. Reicin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 23,000 | 23,000 | - | - | Option (Right to Buy) | |
| Sana Biotechnology Inc | Alise S. Reicin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc. | Alise S. Reicin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 18,000 | 18,000 | - | - | Option (Right to Buy) | |
| Sana Biotechnology Inc | Alise S. Reicin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc. | Alise S. Reicin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 18,000 | 18,000 | - | - | Option (Right to Buy) | |
| Sana Biotechnology Inc | Alise S. Reicin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 11,795 | 11,795 | - | - | Stock Option (Right to Buy) |